$AUXL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AUXILIUM PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AUXILIUM PHARMACEUTICALS INC. Get notifications about new insider transactions in AUXILIUM PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 6 7 ... 7 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 15 2013 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Sell | S | 18.74 | 500 | 9,370 | 15,428 | 15.9 K to 15.4 K (-3.14 %) |
| Aug 15 2013 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Sell | S | 18.73 | 169 | 3,165 | 15,928 | 16.1 K to 15.9 K (-1.05 %) |
| Jul 02 2013 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Grant | A | 16.63 | 450 | 7,484 | 11,828 | 11.4 K to 11.8 K (+3.96 %) |
| Jul 02 2013 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 16.63 | 450 | 7,484 | 22,165 | 21.7 K to 22.2 K (+2.07 %) |
| Jun 25 2013 | AUXL | AUXILIUM PHARMACEU ... | KOVEN ANDREW I | EVP, CAO, GC and Se ... | Payment of Exercise | F | 17.15 | 102 | 1,749 | 22,888 | 23 K to 22.9 K (-0.44 %) |
| Jun 25 2013 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Payment of Exercise | F | 17.15 | 187 | 3,207 | 28,375 | 28.6 K to 28.4 K (-0.65 %) |
| Jun 25 2013 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Payment of Exercise | F | 17.15 | 80 | 1,372 | 45,132 | 45.2 K to 45.1 K (-0.18 %) |
| May 22 2013 | AUXL | AUXILIUM PHARMACEU ... | MCKEE WILLIAM | Director | Sell | S | 15.10 | 2,000 | 30,209 | 8,000 | 10 K to 8 K (-20.00 %) |
| May 03 2013 | AUXL | AUXILIUM PHARMACEU ... | Lurker Nancy | Director | Option Exercise | A | 14.37 | 5,000 | 71,850 | 5,000 | |
| May 03 2013 | AUXL | AUXILIUM PHARMACEU ... | Lurker Nancy | Director | Grant | A | 0.00 | 5,000 | 0 | 12,430 | 7.4 K to 12.4 K (+67.29 %) |
| May 03 2013 | AUXL | AUXILIUM PHARMACEU ... | MCKEE WILLIAM | Director | Option Exercise | A | 14.37 | 5,000 | 71,850 | 5,000 | |
| May 03 2013 | AUXL | AUXILIUM PHARMACEU ... | MCKEE WILLIAM | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
| May 03 2013 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Option Exercise | A | 14.37 | 5,000 | 71,850 | 5,000 | |
| May 03 2013 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Grant | A | 0.00 | 5,000 | 0 | 11,378 | 6.4 K to 11.4 K (+78.39 %) |
| May 03 2013 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Option Exercise | A | 14.37 | 5,000 | 71,850 | 5,000 | |
| May 03 2013 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Grant | A | 0.00 | 5,000 | 0 | 16,097 | 11.1 K to 16.1 K (+45.06 %) |
| May 03 2013 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Option Exercise | A | 14.37 | 5,000 | 71,850 | 5,000 | |
| May 03 2013 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 0.00 | 5,000 | 0 | 21,715 | 16.7 K to 21.7 K (+29.91 %) |
| May 03 2013 | AUXL | AUXILIUM PHARMACEU ... | Brandt Peter C. | Director | Option Exercise | A | 14.37 | 5,000 | 71,850 | 5,000 | |
| May 03 2013 | AUXL | AUXILIUM PHARMACEU ... | Brandt Peter C. | Director | Grant | A | 0.00 | 5,000 | 0 | 20,000 | 15 K to 20 K (+33.33 %) |
| Apr 02 2013 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Grant | A | 17.29 | 433 | 7,487 | 6,378 | 5.9 K to 6.4 K (+7.28 %) |
| Apr 02 2013 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 17.29 | 541 | 9,354 | 16,715 | 16.2 K to 16.7 K (+3.34 %) |
| Mar 05 2013 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Option Exercise | A | 17.59 | 3,575 | 62,884 | 3,575 | |
| Mar 05 2013 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Grant | A | 0.00 | 1,425 | 0 | 4,182 | 2.8 K to 4.2 K (+51.69 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Option Exercise | A | 18.30 | 37,500 | 686,250 | 37,500 | |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Payment of Exercise | F | 18.30 | 426 | 7,796 | 28,562 | 29 K to 28.6 K (-1.47 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Grant | A | 0.00 | 15,200 | 0 | 28,988 | 13.8 K to 29 K (+110.24 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Grant | A | 0.00 | 3,940 | 0 | 13,788 | 9.8 K to 13.8 K (+40.01 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | Tursi James Patrick | Chief Medical Offic ... | Option Exercise | A | 18.30 | 33,000 | 603,900 | 33,000 | |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | Tursi James Patrick | Chief Medical Offic ... | Payment of Exercise | F | 18.30 | 426 | 7,796 | 19,008 | 19.4 K to 19 K (-2.19 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | Tursi James Patrick | Chief Medical Offic ... | Grant | A | 0.00 | 13,200 | 0 | 19,434 | 6.2 K to 19.4 K (+211.74 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | Tursi James Patrick | Chief Medical Offic ... | Grant | A | 0.00 | 3,940 | 0 | 6,234 | 2.3 K to 6.2 K (+171.75 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | KOVEN ANDREW I | EVP, CAO, GC and Se ... | Option Exercise | A | 18.30 | 37,500 | 686,250 | 37,500 | |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | KOVEN ANDREW I | EVP, CAO, GC and Se ... | Payment of Exercise | F | 18.30 | 910 | 16,653 | 22,990 | 23.9 K to 23 K (-3.81 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | KOVEN ANDREW I | EVP, CAO, GC and Se ... | Grant | A | 0.00 | 15,200 | 0 | 23,900 | 8.7 K to 23.9 K (+174.71 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | KOVEN ANDREW I | EVP, CAO, GC and Se ... | Grant | A | 0.00 | 7,700 | 0 | 8,700 | 1,000 to 8.7 K (+770.00 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | JOBES ELIZABETH VARKI | Chief Compliance Of ... | Option Exercise | A | 18.30 | 15,000 | 274,500 | 15,000 | |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | JOBES ELIZABETH VARKI | Chief Compliance Of ... | Grant | A | 0.00 | 6,000 | 0 | 9,000 | 3 K to 9 K (+200.00 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Option Exercise | A | 18.30 | 33,000 | 603,900 | 33,000 | |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Payment of Exercise | F | 18.30 | 426 | 7,796 | 19,316 | 19.7 K to 19.3 K (-2.16 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Grant | A | 0.00 | 13,200 | 0 | 19,742 | 6.5 K to 19.7 K (+201.77 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Grant | A | 0.00 | 3,940 | 0 | 6,542 | 2.6 K to 6.5 K (+151.42 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 18.30 | 37,500 | 686,250 | 37,500 | |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Payment of Exercise | F | 18.30 | 482 | 8,821 | 45,212 | 45.7 K to 45.2 K (-1.05 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Grant | A | 0.00 | 15,200 | 0 | 45,694 | 30.5 K to 45.7 K (+49.85 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Grant | A | 0.00 | 3,940 | 0 | 30,494 | 26.6 K to 30.5 K (+14.84 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Option Exercise | A | 18.30 | 15,000 | 274,500 | 15,000 | |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Payment of Exercise | F | 18.30 | 333 | 6,094 | 13,353 | 13.7 K to 13.4 K (-2.43 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Grant | A | 0.00 | 6,000 | 0 | 13,686 | 7.7 K to 13.7 K (+78.06 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Grant | A | 0.00 | 2,740 | 0 | 7,686 | 4.9 K to 7.7 K (+55.40 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | Armstrong Jennifer Lou | Senior Vice Preside ... | Option Exercise | A | 18.30 | 15,000 | 274,500 | 15,000 | |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | Armstrong Jennifer Lou | Senior Vice Preside ... | Grant | A | 0.00 | 6,000 | 0 | 10,040 | 4 K to 10 K (+148.51 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | Armstrong Jennifer Lou | Senior Vice Preside ... | Grant | A | 0.00 | 2,740 | 0 | 4,040 | 1.3 K to 4 K (+210.77 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | ADAMS ADRIAN | CEO and President | Option Exercise | A | 17.96 | 129,000 | 2,316,840 | 129,000 | |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | ADAMS ADRIAN | CEO and President | Grant | A | 0.00 | 51,600 | 0 | 130,162 | 78.6 K to 130.2 K (+65.68 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | ADAMS ADRIAN | CEO and President | Grant | A | 0.00 | 21,480 | 0 | 78,562 | 57.1 K to 78.6 K (+37.63 %) |
| Feb 05 2013 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Payment of Exercise | F | 18.85 | 398 | 7,502 | 2,602 | 3 K to 2.6 K (-13.27 %) |
| Jan 03 2013 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Gift | G | 0.00 | 1,227 | 0 | 5,945 | 7.2 K to 5.9 K (-17.11 %) |
| Jan 03 2013 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Gift | G | 0.00 | 1,227 | 0 | 7,172 | 8.4 K to 7.2 K (-14.61 %) |
| Jan 03 2013 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Grant | A | 18.54 | 404 | 7,490 | 8,399 | 8 K to 8.4 K (+5.05 %) |
| Jan 03 2013 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Grant | A | 18.54 | 214 | 3,967 | 11,097 | 10.9 K to 11.1 K (+1.97 %) |
| Jan 03 2013 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 18.54 | 404 | 7,490 | 16,174 | 15.8 K to 16.2 K (+2.56 %) |
| Dec 17 2012 | AUXL | AUXILIUM PHARMACEU ... | ADAMS ADRIAN | CEO and President | Buy | P | 0.00 | 56,000 | 0 | 56,579 | 579 to 56.6 K (+9,671.85 %) |
| Oct 31 2012 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Payment of Exercise | F | 21.01 | 826 | 17,354 | 9,848 | 10.7 K to 9.8 K (-7.74 %) |
| Oct 02 2012 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Grant | A | 24.46 | 306 | 7,485 | 7,995 | 7.7 K to 8 K (+3.98 %) |
| Oct 02 2012 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Grant | A | 24.46 | 163 | 3,987 | 10,883 | 10.7 K to 10.9 K (+1.52 %) |
| Oct 02 2012 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 24.46 | 306 | 7,485 | 15,770 | 15.5 K to 15.8 K (+1.98 %) |
| Jul 20 2012 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Option Exercise | A | 26.87 | 10,000 | 268,700 | 10,000 | |
| Jul 03 2012 | AUXL | AUXILIUM PHARMACEU ... | Lurker Nancy | Director | Grant | A | 26.89 | 417 | 11,213 | 7,430 | 7 K to 7.4 K (+5.95 %) |
| Jul 03 2012 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Grant | A | 26.89 | 231 | 6,212 | 7,689 | 7.5 K to 7.7 K (+3.10 %) |
| Jul 03 2012 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Grant | A | 26.89 | 120 | 3,227 | 10,720 | 10.6 K to 10.7 K (+1.13 %) |
| Jul 03 2012 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 26.89 | 220 | 5,916 | 15,464 | 15.2 K to 15.5 K (+1.44 %) |
| Jun 26 2012 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Option Exercise | M | 5.50 | 12,682 | 69,751 | 0 | |
| Jun 26 2012 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Sell | S | 25.01 | 12,682 | 317,155 | 4,470 | 17.2 K to 4.5 K (-73.94 %) |
| Jun 26 2012 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Buy | M | 5.50 | 12,682 | 69,751 | 17,152 | 4.5 K to 17.2 K (+283.71 %) |
| Jun 25 2012 | AUXL | AUXILIUM PHARMACEU ... | KOVEN ANDREW I | EVP, CAO, GC and Se ... | Grant | A | 0.00 | 1,000 | 0 | 1,000 | 0 to 1,000 |
| Jun 25 2012 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Grant | A | 0.00 | 1,500 | 0 | 10,674 | 9.2 K to 10.7 K (+16.35 %) |
| Jun 25 2012 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Grant | A | 0.00 | 750 | 0 | 26,554 | 25.8 K to 26.6 K (+2.91 %) |
| Jun 22 2012 | AUXL | AUXILIUM PHARMACEU ... | Lurker Nancy | Director | Option Exercise | A | 24.62 | 5,000 | 123,100 | 5,000 | |
| Jun 22 2012 | AUXL | AUXILIUM PHARMACEU ... | Lurker Nancy | Director | Grant | A | 0.00 | 5,000 | 0 | 7,013 | 2 K to 7 K (+248.39 %) |
| Jun 22 2012 | AUXL | AUXILIUM PHARMACEU ... | MCKEE WILLIAM | Director | Option Exercise | A | 24.62 | 5,000 | 123,100 | 5,000 | |
| Jun 22 2012 | AUXL | AUXILIUM PHARMACEU ... | MCKEE WILLIAM | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Jun 22 2012 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Option Exercise | A | 24.62 | 5,000 | 123,100 | 5,000 | |
| Jun 22 2012 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Grant | A | 0.00 | 5,000 | 0 | 7,454 | 2.5 K to 7.5 K (+203.75 %) |
| Jun 22 2012 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Option Exercise | A | 24.62 | 5,000 | 123,100 | 5,000 | |
| Jun 22 2012 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Grant | A | 0.00 | 5,000 | 0 | 10,600 | 5.6 K to 10.6 K (+89.29 %) |
| Jun 22 2012 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Option Exercise | A | 24.62 | 5,000 | 123,100 | 5,000 | |
| Jun 22 2012 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 0.00 | 5,000 | 0 | 15,244 | 10.2 K to 15.2 K (+48.81 %) |
| Jun 22 2012 | AUXL | AUXILIUM PHARMACEU ... | Brandt Peter C. | Director | Option Exercise | A | 24.62 | 5,000 | 123,100 | 5,000 | |
| Jun 22 2012 | AUXL | AUXILIUM PHARMACEU ... | Brandt Peter C. | Director | Grant | A | 0.00 | 5,000 | 0 | 15,000 | 10 K to 15 K (+50.00 %) |
| May 09 2012 | AUXL | AUXILIUM PHARMACEU ... | JOBES ELIZABETH VARKI | Chief Compliance Of ... | Option Exercise | A | 17.68 | 40,000 | 707,200 | 40,000 | |
| May 09 2012 | AUXL | AUXILIUM PHARMACEU ... | JOBES ELIZABETH VARKI | Chief Compliance Of ... | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
| Jun 08 2012 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Option Exercise | M | 9.15 | 6,000 | 54,900 | 0 | |
| Jun 08 2012 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Sell | S | 22.55 | 5,700 | 128,536 | 2,024 | 7.7 K to 2 K (-73.80 %) |
| Jun 08 2012 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Sell | S | 22.55 | 300 | 6,766 | 7,724 | 8 K to 7.7 K (-3.74 %) |
| Jun 08 2012 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Buy | M | 9.15 | 6,000 | 54,900 | 8,024 | 2 K to 8 K (+296.44 %) |
| Apr 03 2012 | AUXL | AUXILIUM PHARMACEU ... | FUCHS RENATO | Director | Grant | A | 18.57 | 150 | 2,786 | 1,803 | 1.7 K to 1.8 K (+9.07 %) |
| Apr 03 2012 | AUXL | AUXILIUM PHARMACEU ... | Lurker Nancy | Director | Grant | A | 18.57 | 605 | 11,235 | 2,013 | 1.4 K to 2 K (+42.97 %) |
| Apr 03 2012 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Grant | A | 18.57 | 336 | 6,240 | 2,454 | 2.1 K to 2.5 K (+15.86 %) |
| Apr 03 2012 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Grant | A | 18.57 | 174 | 3,231 | 5,600 | 5.4 K to 5.6 K (+3.21 %) |
| Apr 03 2012 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 18.57 | 319 | 5,924 | 10,244 | 9.9 K to 10.2 K (+3.21 %) |
| Mar 01 2012 | AUXL | AUXILIUM PHARMACEU ... | Brandt Peter C. | Director | Buy | P | 20.10 | 9,700 | 194,970 | 10,000 | 300 to 10 K (+3,233.33 %) |
| Mar 01 2012 | AUXL | AUXILIUM PHARMACEU ... | Brandt Peter C. | Director | Buy | P | 20.09 | 300 | 6,028 | 300 | 0 to 300 |
| Mar 01 2012 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Payment of Exercise | F | 20.07 | 1,053 | 21,134 | 25,786 | 26.8 K to 25.8 K (-3.92 %) |
| Feb 16 2012 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Option Exercise | A | 19.51 | 57,000 | 1,112,070 | 57,000 | |
| Feb 16 2012 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 19.51 | 57,000 | 1,112,070 | 57,000 | |
| Feb 16 2012 | AUXL | AUXILIUM PHARMACEU ... | Tursi James Patrick | Chief Medical Offic ... | Option Exercise | A | 19.51 | 57,000 | 1,112,070 | 57,000 | |
| Feb 16 2012 | AUXL | AUXILIUM PHARMACEU ... | Dudek Richard Michael Jr | Senior Vice Pres., ... | Option Exercise | A | 19.51 | 28,000 | 546,280 | 28,000 | |
| Feb 16 2012 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Option Exercise | A | 19.51 | 28,000 | 546,280 | 28,000 | |
| Feb 16 2012 | AUXL | AUXILIUM PHARMACEU ... | Armstrong Jennifer Lou | Senior Vice Preside ... | Option Exercise | A | 19.51 | 28,000 | 546,280 | 28,000 | |
| Feb 07 2012 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | SVP - Sales | Option Exercise | A | 20.07 | 55,000 | 1,103,850 | 55,000 | |
| Feb 07 2012 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | SVP - Sales | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
| Feb 07 2012 | AUXL | AUXILIUM PHARMACEU ... | KOVEN ANDREW I | EVP, CAO, GC and Se ... | Option Exercise | A | 20.07 | 250,000 | 5,017,500 | 250,000 | |
| Jan 06 2012 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Grant | A | 19.05 | 236 | 4,496 | 2,118 | 1.9 K to 2.1 K (+12.54 %) |
| Jan 06 2012 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Grant | A | 19.05 | 141 | 2,686 | 5,426 | 5.3 K to 5.4 K (+2.67 %) |
| Jan 06 2012 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 19.05 | 118 | 2,248 | 9,925 | 9.8 K to 9.9 K (+1.20 %) |
| Jan 04 2012 | AUXL | AUXILIUM PHARMACEU ... | Lurker Nancy | Director | Grant | A | 19.93 | 563 | 11,221 | 1,408 | 845 to 1.4 K (+66.63 %) |
| Jan 04 2012 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 19.93 | 297 | 5,919 | 9,807 | 9.5 K to 9.8 K (+3.12 %) |
| Jan 04 2012 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Grant | A | 19.93 | 312 | 6,218 | 1,882 | 1.6 K to 1.9 K (+19.87 %) |
| Jan 04 2012 | AUXL | AUXILIUM PHARMACEU ... | FUCHS RENATO | Director | Grant | A | 19.93 | 140 | 2,790 | 1,653 | 1.5 K to 1.7 K (+9.25 %) |
| Jan 04 2012 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Grant | A | 19.93 | 244 | 4,863 | 5,285 | 5 K to 5.3 K (+4.84 %) |
| Dec 09 2011 | AUXL | AUXILIUM PHARMACEU ... | ADAMS ADRIAN | CEO and President | Option Exercise | A | 17.40 | 550,000 | 9,570,000 | 550,000 | |
| Nov 07 2011 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Buy | P | 15.54 | 1,610 | 25,024 | 26,839 | 25.2 K to 26.8 K (+6.38 %) |
| Nov 03 2011 | AUXL | AUXILIUM PHARMACEU ... | Kessig Edward F | Senior Vice Preside ... | Option Exercise | A | 15.12 | 15,000 | 226,800 | 15,000 | |
| Nov 03 2011 | AUXL | AUXILIUM PHARMACEU ... | Dudek Richard Michael Jr | Senior Vice Pres., ... | Option Exercise | A | 15.12 | 15,000 | 226,800 | 15,000 | |
| Oct 27 2011 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Payment of Exercise | F | 15.98 | 826 | 13,199 | 9,174 | 10 K to 9.2 K (-8.26 %) |
| Nov 03 2011 | AUXL | AUXILIUM PHARMACEU ... | Armstrong Jennifer Lou | Senior Vice Preside ... | Option Exercise | A | 15.12 | 15,000 | 226,800 | 15,000 | |
| Oct 11 2011 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Option Exercise | M | 7.81 | 5,275 | 41,198 | 378,340 | |
| Oct 11 2011 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Sell | S | 14.23 | 5,275 | 75,046 | 13,653 | 18.9 K to 13.7 K (-27.87 %) |
| Oct 11 2011 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Buy | M | 7.81 | 5,275 | 41,198 | 18,928 | 13.7 K to 18.9 K (+38.64 %) |
| Oct 04 2011 | AUXL | AUXILIUM PHARMACEU ... | Lurker Nancy | Director | Grant | A | 14.99 | 750 | 11,243 | 845 | 95 to 845 (+789.47 %) |
| Oct 04 2011 | AUXL | AUXILIUM PHARMACEU ... | FUCHS RENATO | Director | Grant | A | 14.99 | 186 | 2,788 | 1,513 | 1.3 K to 1.5 K (+14.02 %) |
| Oct 04 2011 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Grant | A | 14.99 | 416 | 6,236 | 1,570 | 1.2 K to 1.6 K (+36.05 %) |
| Oct 04 2011 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Grant | A | 14.99 | 325 | 4,872 | 5,041 | 4.7 K to 5 K (+6.89 %) |
| Oct 04 2011 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 14.99 | 545 | 8,170 | 9,510 | 9 K to 9.5 K (+6.08 %) |
| Aug 03 2011 | AUXL | AUXILIUM PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 17.25 | 1,001 | 17,265 | 132,889 | 133.9 K to 132.9 K (-0.75 %) |
| Aug 03 2011 | AUXL | AUXILIUM PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 18.04 | 9,678 | 174,580 | 133,890 | 143.6 K to 133.9 K (-6.74 %) |
| Aug 03 2011 | AUXL | AUXILIUM PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 18.03 | 6,400 | 115,389 | 143,568 | 150 K to 143.6 K (-4.27 %) |
| Aug 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Tursi James Patrick | Chief Medical Offic ... | Option Exercise | A | 14.10 | 50,000 | 705,000 | 50,000 | |
| Aug 03 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 17.25 | 6,361 | 109,715 | 844,839 | 851.2 K to 844.8 K (-0.75 %) |
| Aug 03 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 18.04 | 61,519 | 1,109,735 | 851,200 | 912.7 K to 851.2 K (-6.74 %) |
| Aug 03 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 18.03 | 40,690 | 733,620 | 912,719 | 953.4 K to 912.7 K (-4.27 %) |
| Aug 03 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 17.25 | 40,781 | 703,391 | 5,416,304 | 5.5 M to 5.4 M (-0.75 %) |
| Aug 03 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 18.04 | 394,404 | 7,114,614 | 5,457,085 | 5.9 M to 5.5 M (-6.74 %) |
| Aug 03 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 18.03 | 260,868 | 4,703,320 | 5,851,489 | 6.1 M to 5.9 M (-4.27 %) |
| Aug 03 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 17.25 | 507 | 8,745 | 67,322 | 67.8 K to 67.3 K (-0.75 %) |
| Aug 03 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 18.04 | 4,902 | 88,427 | 67,829 | 72.7 K to 67.8 K (-6.74 %) |
| Aug 03 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 18.03 | 3,243 | 58,470 | 72,731 | 76 K to 72.7 K (-4.27 %) |
| Jul 12 2011 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Option Exercise | M | 7.81 | 5,275 | 41,198 | 383,615 | |
| Jul 12 2011 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Sell | S | 20.30 | 5,275 | 107,101 | 13,653 | 18.9 K to 13.7 K (-27.87 %) |